As Enhertu’s reach continues to spread into additional forms of breast cancer, Daiichi Sankyo and AstraZeneca are ramping up ...

Gilead Sciences’ Kite Pharma will sell its stake in China’s Fosun Kite Biotechnology nearly eight years after forming the ...

The Deerfield life sciences agency has bolstered its comms and marketing team with two new senior hires. | The Deerfield life ...

From truckloads of torn documents to avian incursions in the production plant, Granules India’s recent manufacturing ...

In a bid to break down barriers facing both pharmas and payers in the life sciences industry, AscellaHealth has begun ...

Gavi, the Vaccine Alliance and the U.K. government ordered a combined 650,000 doses of Bavarian Nordic’s Jynneos mpox vaccine ...

No longer a far-off futuristic idea, artificial intelligence technology has seen its popularity skyrocket in recent years. | ...

In the study, co-administration of GSK's RSV vaccine Arexvy and shingles shot Shingrix elicited non-inferior immune responses ...

Theratechnologies’ supply hiccup is the second caused by third-party manufacturing problems in less than a week. On Friday, ...

Just a few months after the reveal of Ori Biotech’s automated cell and gene therapy manufacturing platform IRO, the technical ...

Since GSK’s Nucala and AstraZeneca’s Fasenra were approved two years apart to treat patients with severe asthma, the IL-5 ...

With its latest acquisition, women’s health outfit Organon is bringing its dermatology business to the U.S. with a potential ...